5 Top Stock Gainers for Tuesday: Vaxart, Precipio, Gartner
Stocks finished mixed Tuesday as investors rotated out of shares of tech companies and headed for higher-yielding value stocks.
Here are some of the top gainers for Tuesday:
1. Vaxart | Increase 9.2%
Shares of Vaxart (VXRT) - Get Vaxart Inc. Report jumped after the drugmaker said its oral COVID-19 vaccine treatment could be just as effective as the injectables made by its most popular rivals.
The biopharma reported broad cross-reactivity against coronaviruses.
2. Precipio | Increase 7.7%
Precipio (PRPO) - Get Precipio Inc. Report continued to climb, one day after the medical diagnostics company said it had launched its COVID-19 rapid antibody test on Amazon's (AMZN) - Get Amazon.com Inc. Report business platform.
The test is the first U.S.-based test to receive emergency-use authorization from the Food and Drug Administration for the point of care.
TheStreet Recommends
3. Gartner | Increase 14%
Gartner (IT) - Get Gartner Inc. Report was surging after the research and advisory company reported better-than-expected first-quarter earnings.
Gartner reported income of $164.1 million, or $1.84 a share, more than double the $75 million, or 83 cents a share, of a year earlier.
4. Domtar | Increase 19%
Shares of Domtar (UFS) - Get Domtar Corporation Report jumped after the paper products company confirmed news reports that it had been in discussions with privately held Canadian company Paper Excellence about a possible acquisition or business combination.
Domtar said the "discussions may or may not result in an agreement."
5. BioLineRX | Increase 53%
BioLineRX (BLRX) - Get BioLineRx Ltd. Report leaped after the biopharma announced positive results from a Phase 3 trial of Motixafortide, its treatment for multiple myeloma patients. The company said the study met all primary and secondary endpoints with an exceptionally high level of statistical significance.
Amazon is a holding in Jim Cramer's Action Alerts PLUS member club. Want to be alerted before Jim Cramer buys or sells AMZN? Learn more now.
